All Bacteria articles – Page 10
-
NewsA rapid and reproducible method for generating germ-free Drosophila melanogaster
Scientists have introduced a refined method for the production of germ-free Drosophila, complemented by a straightforward verification process to ascertain its efficacy.
-
NewsA*STAR spin-off NalaGenetics implements nationwide drug reaction screening for leprosy patients in Indonesia
NalaGenetics, a spin-off from A*STAR Genome Institute of Singapore (A*STAR GIS), will be transforming leprosy treatments in Indonesia with a nationwide genetic screening programme with their PGx1301 diagnostic kit.
-
NewsMicrobiologist calls for urgent action on the danger of raw sewage in UK seas
A microbiologist has described how he contracted a type of bacterial pneumonia following a swim in the sea that was likely connected to an incident of sewage dumping in the area.
-
NewsNew insights into how specific gut cells respond to bacterial toxins
Researchers have characterized a specific gut cell type, BEST4/CA7+ cells, with the ability to interact with immune cytokine interferon-γ (IFNγ), and its regulation in cellular electrolyte and water balance, in response to bacterial toxins.
-
NewsNew insights into phage–bacteria interactions in the gut microbiome
Researchers studied the interactions between bacteria and phages within the gut microbiome and highlighted the significance of the phage community to shape the microbiome that contributes to host health and diseases.
-
NewsDesigning self-destructing bacteria to make effective tuberculosis vaccines
Preclinical studies have demonstrated a more effective tuberculosis (TB) vaccine through engineering bacteria to self-destruct and swiftly stops the infection on cue, which activates a more robust immune response.
-
NewsBacteria consumed by immune cells become part of the cell
Immune cells that eat bacteria in the body don’t stash them in specialized compartments as once thought, but turn them into critical nutrients that build proteins, create energy and keep the cells alive, according to a new study.
-
OpinionThe problem of microplastics in the oceans: it’s time for effective solutions
Francielly Bruna Neto Francisco and Ricardo Henrique Krüger, from the University of Brasília (UNB), warn that we urgently need technologies that will effectively eliminate partially or nonbiodegradable polymers from the marine environment.
-
NewsStudy probes light-harvesting proteins of purple sulfur bacteria in high-salt, high-alkaline environments
Halorhodospira halophila, a purple sulfur bacterium, is believed to perform photosynthesis efficiently by integrating light harvesting protein complexes LH2 and LH1-RC. Researchers employed cryo-electron microscopy to investigate.
-
NewsSuperbugs in our food: a new hope for tackling drug resistance
Researchers highlight the potential of quorum sensing inhibitors (QSIs) as a novel approach to tackle Pseudomonas aeruginosa. The study explores the mechanisms of action of various QSIs and potential applications in food safety and healthcare.
-
NewsStudy reveals how bacteria in microbiome medicine trigger tumor-killing cells
Microbiotica has presented new data on the mechanism of action of MB097, a clinical-stage drug candidate being developed as a co-therapy in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma.
-
NewsFungi more vulnerable than bacteria in degrading alpine ecosystems
A new study provides the first evidence that alpine pioneer community degradation led to declines of 27% in fungal richness, 8% in bacterial richness and about 50% of endemic microorganisms.
-
NewsBeacon Technology Solutions, Illinois Tech awarded grant to advance far-UVC disinfection research
Beacon Technology Solutions, with collaborators at Illinois Institute of Technology, has been awarded a grant to support a novel study on how Far-UVC technology can help mitigate the spread of infectious diseases in public spaces.
-
NewsNeutrophil-to-lymphocyte ratio and its correlation with tuberculosis infection
A new study reveals a significant negative correlation between neutrophil-to-lymphocyte ratio (NLR) and the risk of tuberculosis infection (TBI), particularly in males and individuals with hypertension.
-
NewsUnexpected species-specific patterns in study of giraffe gut flora
The gut bacteria of giraffes are not primarily determined by what they eat, but by the species they belong to., according to a new study analysing the link between diet and gut flora in three giraffe species in Kenya. The study also provides new knowledge that can help secure the food supply of endangered giraffe species.
-
NewsLaser-powered device tested on Earth could help us detect microbial fossils on Mars
Scientists hoping to identify fossil evidence of ancient Martian microbial life have now found a way to test their hypothesis, proving they can detect the fossils of microbes in gypsum samples that are a close analogy to sulfate rocks on Mars.
-
NewsStromatolite study provides new detail on the impact of volcanic activity on early marine life
Analysis of fossilised rocks known as stromatolites - layered rock formations created by ancient microorganisms, such as bacteria - from more than two-and-a-half billion years ago has provided new insights into the conditions on Earth before the evolution of oxygen.
-
NewsLactobacillus-dominated uterus significantly boosts pregnancy outcomes
Researchers analyzed recent studies on the reproductive microbiome and its effects on fertility. They found that a Lactobacillus-dominated (LD) uterine environment significantly improves pregnancy outcomes. Similarly, pregnancy success rates were higher in LD environments.
-
NewsResearch suggests common viral infection worsens deadly condition among premature babies
Researchers say they found that infection with a common virus that can be transmitted from mother to fetus before birth significantly worsens an often-fatal complication of premature birth called necrotizing enterocolitis (NEC) in experiments with mice.
-
NewsScientists invent new drug candidates to treat antibiotic-resistant bacteria
Researchers designed a new family of antibiotics that’s a variation of an existing drug called vancomycin, which is used as a last resort for extremely ill patients. The new version of vancomycin targets, bonds to and renders inactive two different parts of a molecule on the surfaces of pathogenic bacteria.